Search - tctmd.com

Displaying 1 - 20 of 56

Sort: Relevancy | Date

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

L.A. McKeown

December 13, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

Todd Neale

January 11, 2024

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Conference News HFSA 2023

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

L.A. McKeown

October 18, 2023

News Conference News EHRA 2023

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Michael O'Riordan

April 19, 2023

News Conference News EHRA 2023

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

Michael O'Riordan

April 18, 2023

Advertisement

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

April 2025 Dispatch for the CV Team

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

March 2025 Dispatch for the CV Team

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

August 2024 Dispatch for the CV Team

June 2024 Dispatch for the CV Team

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

May 2024 Dispatch for the CV Team

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help

AHA Selects 2023’s Leading Cardiovascular Research

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content